©️ IP & Copyright
Brazil's Cannabis Trademarks: BPTO's Patchwork Mess
Brazil's inching toward cannabis leniency, but trademark protection? A bureaucratic nightmare. Here's why smart lawyers are already gaming the system.
theAIcatchup
Apr 09, 2026
3 min read
⚡ Key Takeaways
-
BPTO inconsistently approves cannabis trademarks, favoring medical products with vague specs.
𝕏
-
Workarounds like Mevatyl show savvy lawyering beats outright bans.
𝕏
-
Shifting laws promise more access, but IP chaos benefits big pharma and attorneys most.
𝕏
The 60-Second TL;DR
- BPTO inconsistently approves cannabis trademarks, favoring medical products with vague specs.
- Workarounds like Mevatyl show savvy lawyering beats outright bans.
- Shifting laws promise more access, but IP chaos benefits big pharma and attorneys most.
Published by
theAIcatchup
Where law meets technology.
Worth sharing?
Get the best Legal Tech stories of the week in your inbox — no noise, no spam.